IL88205A0 - Novel pyridine compounds and compositions for the treatment of osteoporosis - Google Patents

Novel pyridine compounds and compositions for the treatment of osteoporosis

Info

Publication number
IL88205A0
IL88205A0 IL88205A IL8820588A IL88205A0 IL 88205 A0 IL88205 A0 IL 88205A0 IL 88205 A IL88205 A IL 88205A IL 8820588 A IL8820588 A IL 8820588A IL 88205 A0 IL88205 A0 IL 88205A0
Authority
IL
Israel
Prior art keywords
osteoporosis
compositions
treatment
pyridine compounds
novel pyridine
Prior art date
Application number
IL88205A
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of IL88205A0 publication Critical patent/IL88205A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
IL88205A 1987-10-30 1988-10-28 Novel pyridine compounds and compositions for the treatment of osteoporosis IL88205A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704248A SE8704248D0 (en) 1987-10-30 1987-10-30 MEDICAL USE

Publications (1)

Publication Number Publication Date
IL88205A0 true IL88205A0 (en) 1989-06-30

Family

ID=20370069

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88205A IL88205A0 (en) 1987-10-30 1988-10-28 Novel pyridine compounds and compositions for the treatment of osteoporosis

Country Status (9)

Country Link
EP (1) EP0339071A1 (en)
JP (1) JPH02501929A (en)
KR (1) KR890701587A (en)
AU (1) AU2620388A (en)
DK (1) DK322189D0 (en)
HU (1) HU203663B (en)
IL (1) IL88205A0 (en)
SE (1) SE8704248D0 (en)
WO (1) WO1989003833A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299470B1 (en) * 1987-07-16 1996-12-04 Byk Gulden Lomberg Chemische Fabrik GmbH Imidazo[1,2-a]pyridines
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
JPH11505524A (en) * 1995-05-01 1999-05-21 藤沢薬品工業株式会社 Imidazo 1,2-A pyridine and imidazo 1,2-A pyrididine derivatives and their use as bone resorption inhibitors
GB9518552D0 (en) * 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New heterocyclic compounds
EP1928237A4 (en) 2005-09-02 2011-03-09 Abbott Lab Novel imidazo based heterocycles
JP5918264B2 (en) 2010-12-22 2016-05-18 アッヴィ・インコーポレイテッド Hepatitis C inhibitor and use thereof
DE102012200349A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted fused pyrimidines and triazines and their use
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9776997B2 (en) 2013-06-04 2017-10-03 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-A]pyridines and their use
MX2016000258A (en) 2013-07-10 2016-04-28 Bayer Pharma AG Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof.
CN106459090A (en) 2014-02-19 2017-02-22 拜耳制药股份公司 3-(pyrimidine-2-yl)imidazo[1,2-A]pyridines
WO2015140199A1 (en) 2014-03-21 2015-09-24 Bayer Pharma Aktiengesellschaft Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
JP2017514899A (en) * 2014-05-02 2017-06-08 バイエル・ファルマ・アクティエンゲゼルシャフト Heterocyclyl- and heteroaryl-substituted imidazo [1,2-a] pyridines and uses thereof
CA2947374A1 (en) 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
US20170101407A1 (en) * 2014-05-02 2017-04-13 Bayer Pharma Aktiengesellschaft 6-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
US10174021B2 (en) 2014-12-02 2019-01-08 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-A]pyridines and their use
JP2017536396A (en) 2014-12-02 2017-12-07 バイエル・ファルマ・アクティエンゲゼルシャフト Heteroaryl substituted imidazo [1,2-a] pyridines and uses thereof
CN107567451A (en) 2015-02-05 2018-01-09 拜耳制药股份公司 As the soluble guanylate cyclase for treating angiocardiopathy（SGC）The carboxamides derivatives of 8 [(2,6 difluorobenzyl) epoxide] 2,6 dimethyl-imidazos [1,2 A] pyrazine 3 of the N substitutions of stimulant
WO2016124565A1 (en) 2015-02-05 2016-08-11 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
WO2018184976A1 (en) 2017-04-05 2018-10-11 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyridinecarboxamides and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3446778A1 (en) * 1984-12-21 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach NEW IMIDAZO DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
HU203663B (en) 1991-09-30
SE8704248D0 (en) 1987-10-30
WO1989003833A1 (en) 1989-05-05
KR890701587A (en) 1989-12-21
DK322189A (en) 1989-06-28
HUT51138A (en) 1990-04-28
EP0339071A1 (en) 1989-11-02
DK322189D0 (en) 1989-06-28
JPH02501929A (en) 1990-06-28
AU2620388A (en) 1989-05-23

Similar Documents

Publication Publication Date Title
IL88205A0 (en) Novel pyridine compounds and compositions for the treatment of osteoporosis
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
ZA883850B (en) Treatment of materials
GB8700398D0 (en) Compositions for surface treatment
ZA857081B (en) Composition for the treatment of allergy
ZA881791B (en) Therapeutic compositions
GB8713769D0 (en) Compositions of matter
IL88745A0 (en) Mixed compositions for treating hypercholesterolemia
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
ZA882963B (en) New ophtalmological composition of matter
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
GB8715966D0 (en) Compositions of matter
PT85027A (en) Process for the preparation of substituted 3-amino-2-benzoylcyclohexen-2-ones and of herbicidal compositions containing them
PT84784B (en) Process for the preparation of benzoxazolyl- and benzothiazolylanilines and of fungicidal compositions containing the same
IL74373A0 (en) Process for the preparation of diaminopyridines
PH24312A (en) Treatment of osteoporosis
AR243320A1 (en) Compositions of matter
GB8712396D0 (en) Composition of matter
PH21642A (en) Treatment of osteoporosis
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
GB8705183D0 (en) Compositions of matter
GB8703068D0 (en) Compositions of matter
ZA889130B (en) Compositions for the reduction of phlebectasiae and process for preparing same
ZA844311B (en) Improved compositions for the treatment of psoriasis
GB8703235D0 (en) Compositions for treatment of cellulosic materials